08J

8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine

08J as a free ligand exists in 2 entries. Examples include: 5TE8 3U5K

Find related ligands: Stereoisomers Similar ligands Chemical Structure Search

View summary at Ligand Expo



Chemical Component Summary

Name8-chloro-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
Identifiers8-chloranyl-6-(2-fluorophenyl)-1-methyl-4H-imidazo[1,5-a][1,4]benzodiazepine
FormulaC18 H13 Cl F N3
Molecular Weight325.77
TypeNON-POLYMER
Isomeric SMILESCc1ncc2CN=C(c3ccccc3F)c3cc(Cl)ccc3-n12
InChIInChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3
InChIKeyDDLIGBOFAVUZHB-UHFFFAOYSA-N

Chemical Details

Formal Charge0
Atom Count36
Chiral Atom Count0
Chiral Atomsn/a
Bond Count39
Aromatic Bond Count17
Leaving Atomsn/a

Drug Info: DrugBank

DrugBank IDDB00683 Different stereochemistry
NameMidazolam
Groups
  • approved
  • illicit
DescriptionA short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH. [PubChem] Midazolam is a schedule IV drug in the United States.
Synonyms
  • Buccolam
  • Dormicum
  • Midazolam
  • Midazolamum
Salts
  • Midazolam Hydrochloride
  • Midazolam maleate
Brand Names
  • Apo-midazolam Injectable 1 mg/ml
  • Apo-midazolam Injectable 5 mg/ml
  • Midazolam
  • Midazolam HCl
  • Midazolam
Affected OrganismHumans and other mammals
IndicationThe midazolam injection is indicated for preoperative sedation/anziolysis/amnesia. It is also an agent for sedation/anziolysis/amnesia prior to or during diagnostic, therapeutic, or endoscopic procedures. Midazolam can also be given intravenously for induction of general anaesthesia.
PharmacologyMidazolam is a short-acting benzodiazepine central nervous system (CNS) depressant. Pharmacodynamic properties of midazolam and its metabolites, which are similar to those of other benzodiazepines, include sedative, anxiolytic, amnesic and hypnotic activities. Benzodiazepine pharmacologic effects appear to result from reversible interactions with the (gamma)-amino butyric acid (GABA) benzodiazepine receptor in the CNS, the major inhibitory neurotransmitter in the central nervous system. The action of midazolam is readily reversed by the benzodiazepine receptor antagonist, flumazenil.
Mechanism of actionIt is thought that the actions of benzodiazepines such as midazolam are mediated through the inhibitory neurotransmitter gamma-aminobutyric acid (GABA), which is one of the major inhibitory neurotransmitters in the brain. Benzodiazepines increase the activity of GABA, thereby producing a calming effect, relaxing skeletal muscles, and inducing sleep. Benzodiazepines bind to the benzodiazepine site on GABA-A receptors, which potentiates the effects of GABA by increasing the frequency of chloride channel opening.
Route of administration
  • Buccal
  • Intramuscular; Intravenous
  • Intravenous
  • Oral
Categories
  • Adjuvants, Anesthesia
  • Anesthetics
  • Anesthetics, General
  • Anesthetics, Intravenous
  • Anti-Anxiety Agents
ATC-CodeN05CD08
AHFS-Code28:24.08
CAS number59467-70-8

Drug Targets

NameSequence SearchPharmacological ActionActions
Gamma-aminobutyric acid receptor subunit deltaMDAPARLLAPLLLLCAQQLRGTRAMNDIGDYVGSNLEISWLPNLDGLIAG...yespotentiator
Gamma-aminobutyric acid receptor subunit deltaMDAPARLLAPLLLLCAQQLRGTRAMNDIGDYVGSNLEISWLPNLDGLIAG...yespotentiator
Gamma-aminobutyric acid receptor subunit rho-2MPYFTRLILFLFCLMVLVESRKPKRKRWTGQVEMPKPSHLYKKNLDVTKI...yespotentiator
Gamma-aminobutyric acid receptor subunit gamma-2MSSPNIWSTGSSVYSTPVFSQKMTVWILLLLSLYPGFTSQKSDDDYEDYA...yespotentiator
Gamma-aminobutyric acid receptor subunit gamma-2MSSPNIWSTGSSVYSTPVFSQKMTVWILLLLSLYPGFTSQKSDDDYEDYA...yespotentiator
View More
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682